Tag: eli lilly

May 14, 2019

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
December 19, 2018

Biotech Outlook 2019: Will the Pressure Continue?

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
December 19, 2018

Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies

Eli Lilly (NYSE:LLY) and Aduro Biotech (NASDAQ:ADRO) today announced a research collaboration and exclusive license agreement for Aduro’s cGAS-STING Pathway...
November 26, 2018

Chi-Med and Eli Lilly Launch Elunate in China

The drug is available in capsule form to treat metastatic colorectal cancer for patients that have undergone previous treatments.
November 26, 2018

Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate)

Hutchison China MediTech (AIM/Nasdaq: HCM) today announces the first commercial launch of fruquintinib capsules (Elunate) with the initiation of product...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?